feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Raleigh Convention Center fire

trending

Game Awards Players' Voice nominees

trending

Mavericks injury report lists eight

trending

Odell Beckham Jr. contract struggles

trending

Devin Booker groin injury

trending

Apple M5 MacBook Pro review

trending

TSA Confirm.ID verification fee

trending

SpaceX launches Starlink satellites

trending

Puducherry schools closed, cyclone Ditwah

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / ART Saves Lives: Maya's Journey Defies HIV Odds

ART Saves Lives: Maya's Journey Defies HIV Odds

1 Dec

•

Summary

  • Maya Kate, diagnosed in 2004, now thrives 20 years later on ART.
  • Antiretroviral therapy transformed HIV into a manageable chronic condition.
  • Global access to ART is now at 92%, but stigma remains a challenge.
ART Saves Lives: Maya's Journey Defies HIV Odds

Maya Kate's journey with HIV began in 2004, marked by the devastating loss of her husband and son to AIDS in 2005. She lived with the constant fear of succumbing to the virus herself, but her determination to live for her daughter fueled her fight.

Starting Antiretroviral Therapy (ART) in 2007, Maya initially struggled with side effects but persevered. ART has since transformed HIV into a manageable chronic condition, enabling her to live a full life for two decades. Her viral load is now undetectable, and she actively supports others facing similar challenges.

Globally, access to ART has reached nearly 92% of people living with HIV, a monumental achievement in making treatment affordable. However, Dr. I S Gilada highlights that stigma and discrimination remain critical barriers that require innovative solutions to overcome.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
ART is a combination of HIV medicines used to control the virus, transforming HIV into a manageable chronic condition.
Maya initially faced immense stigma and fear, but found strength in her mother's support and later, in ART and her role as a peer counselor.
While ART is widely accessible, stigma, discrimination, and ensuring consistent treatment, especially for mother-to-child transmission prevention, remain major challenges.

Read more news on

Healthside-arrow

You may also like

GP Reveals Key COVID Symptom to Spot

29 Nov • 13 reads

article image

Can Full-Body Scans Save Your Life? Journalists Investigate

27 Nov • 25 reads

article image

Doctor's Top Tips to Prevent Child Injuries

22 Nov • 43 reads

article image

Coral Implant Offers New Hope for Knee Osteoarthritis Patients

17 Nov • 69 reads

article image

Hospitals Strive to Convert Travel Nurses into Permanent Staff

13 Nov • 29 reads

article image